Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
- PMID: 25643909
- PMCID: PMC4355279
- DOI: 10.1158/2159-8290.CD-14-1205
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
Abstract
Large and comprehensive genomic surveys of head and neck squamous cell carcinomas (HNSCC) are now greatly increasing our understanding of the diversity of this disease and the key genomic changes that drive these tumors. The results from these studies are beginning to inform the introduction of novel therapies for patients with HNSCCs. Here, we review some of the key findings from recent genomic studies of head and neck cancers, including the most comprehensive study to date from The Cancer Genome Atlas Network.
©2015 American Association for Cancer Research.
Conflict of interest statement
The authors report no relevant conflicts of interest.
Similar articles
-
Molecular Aspects of Head and Neck Cancer Therapy.Hematol Oncol Clin North Am. 2015 Dec;29(6):971-92. doi: 10.1016/j.hoc.2015.07.003. Epub 2015 Oct 17. Hematol Oncol Clin North Am. 2015. PMID: 26568543 Free PMC article. Review.
-
TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.Cancer. 2017 May 15;123(10):1778-1790. doi: 10.1002/cncr.30570. Epub 2017 Mar 13. Cancer. 2017. PMID: 28295222 Free PMC article.
-
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.Clin Cancer Res. 2015 Feb 1;21(3):632-41. doi: 10.1158/1078-0432.CCR-13-3310. Epub 2014 Jul 23. Clin Cancer Res. 2015. PMID: 25056374 Free PMC article.
-
Novel treatments for head and neck squamous cell carcinoma: preclinical identification and clinical investigation.Future Oncol. 2014 May;10(6):1065-80. doi: 10.2217/fon.14.18. Future Oncol. 2014. PMID: 24941990 Review.
-
[Genomic characterization of head and neck squamous cell carcinoma: Impact and challenges for therapeutic management].Bull Cancer. 2018 Sep;105(9):820-829. doi: 10.1016/j.bulcan.2018.05.011. Epub 2018 Jun 22. Bull Cancer. 2018. PMID: 29937334 Review. French.
Cited by
-
Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma.Onco Targets Ther. 2020 Aug 21;13:8395-8411. doi: 10.2147/OTT.S257200. eCollection 2020. Onco Targets Ther. 2020. PMID: 32904613 Free PMC article.
-
Immuno-Oncological Biomarkers for Squamous Cell Cancer of the Head and Neck: Current State of the Art and Future Perspectives.Cancers (Basel). 2021 Apr 4;13(7):1714. doi: 10.3390/cancers13071714. Cancers (Basel). 2021. PMID: 33916646 Free PMC article. Review.
-
Long non-coding RNA LOC541471: A novel prognostic biomarker for head and neck squamous cell carcinoma.Oncol Lett. 2019 Feb;17(2):2457-2464. doi: 10.3892/ol.2018.9831. Epub 2018 Dec 14. Oncol Lett. 2019. PMID: 30675311 Free PMC article.
-
Trametinib improves Treg selectivity of anti-CCR4 antibody by regulating CCR4 expression in CTLs in oral squamous cell carcinoma.Sci Rep. 2022 Dec 15;12(1):21678. doi: 10.1038/s41598-022-22773-1. Sci Rep. 2022. PMID: 36522365 Free PMC article.
-
Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers.Front Immunol. 2022 Jun 29;13:835997. doi: 10.3389/fimmu.2022.835997. eCollection 2022. Front Immunol. 2022. PMID: 35844493 Free PMC article. Review.
References
-
- Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med. 1993;328(3):184–194. - PubMed
-
- Ang KK, Chen A, Curran WJ, Jr, Garden AS, Harari PM, Murphy BA, et al. Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN) Cancer. 2012;118(23):5783–5792. - PubMed
-
- Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–1474. - PubMed
-
- Janot F, de Raucourt D, Benhamou E, Ferron C, Dolivet G, Bensadoun RJ, et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol. 2008;26(34):5518–5523. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical